The DOI matches its Crossref record.
Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
Abstract
SLE is a disease characterized by the generation of an immune response to intact nuclear Ags, especially components of the nucleosome, histones and DNA. The process of programmed cell death, or apoptosis, is characterized by cleavage of chromatin into oligonucleosomes and release of these nucleosomes into the extracellular space. To address the question of whether altered apoptosis might provide a source of extracellular nuclear Ags in SLE, we have examined apoptosis of lymphocytes isolated from patients with SLE, patients with rheumatoid arthritis (RA), and normal controls. Apoptosis was measured by three independent methods and confirmed by gel electrophoresis. Freshly isolated lymphocytes (t0) showed low levels of apoptosis. However, lymphocytes from SLE patients demonstrated a significant increase in the number of apoptotic cells at t0 compared with normal controls and RA patients. In tissue culture, lymphocytes from all patient groups underwent apoptosis, but the rate of apoptosis of lymphocytes derived from SLE patients was 2.35-fold faster than apoptosis of lymphocytes from normal controls or RA patients. The increased rate of apoptosis could not be accounted for by corticosteroid or cytotoxic medication. There was a significant correlation between SLE disease activity as measured by the systemic lupus activity measure and rate of apoptosis in vitro. The release of intact nucleosomes during apoptosis was measured by ELISA; lymphocytes from SLE patients released increased amounts of nucleosomal material into the extracellular space in direct proportion to the rate of apoptosis. Abnormal apoptosis of lymphocytes in SLE may provide a source of extracellular nuclear Ag to drive the immune response and to allow the formation of immune complexes. The demonstration of altered in vitro apoptosis of lymphocytes derived from SLE patients raises the possibility that abnormalities of apoptosis may contribute to the pathogenesis of SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Théry, C., Boussac, M., Véron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., & Amigorena, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7309 · Cited by 1,563
Pathogenesis of systemic lupus erythematosus
Mok, C. C., & Lau, C. S. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.7.481 · Cited by 942
Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., & Kalden, J. R. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1241::aid-art15>3.0.co;2-h · Cited by 839
Surface exposure of phosphatidylserine in pathological cells
Zwaal, R. F. A., Comfurius, P., & Bevers, E. M. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4527-3 · Cited by 753
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Apoptosis: Molecular Regulation of Cell Death
Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneman, V. E. A., Longthorne, V. L., Culhane, A. C., & Williams, G. T. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00001.x · Cited by 656
Systemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production
Mevorach, D., Zhou, J. L., Song, X., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.387 · Cited by 567
Lövgren, T., Eloranta, M., Båve, U., Alm, G. V., & Rönnblom, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20254 · Cited by 552
Apoptosis: mechanisms and clinical implications
Kam, P. C. A., & Ferch, N. I. (2000) · Anaesthesia · doi:10.1046/j.1365-2044.2000.01554.x · Cited by 455
Apoptosis in rheumatoid arthritis synovium.
Firestein, G. S., Yeo, M., & Zvaifler, N. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118202 · Cited by 383
Båve, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G. V., & Rönnblom, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3296 · Cited by 380
Interaction of aldehydes derived from lipid peroxidation and membrane proteins
Pizzimenti, S., Ciamporcero, E., Daga, M., Pettazzoni, P., Arcaro, A., Cetrangolo, G., Minelli, R., Dianzani, C., Lepore, A., Gentile, F., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00242 · Cited by 380
Ren, Y., Tang, J., Mok, M. Y., Chan, A. W. K., Wu, A., & Lau, C. S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11237 · Cited by 349
Funk, J. L., Cordaro, L. A., Wei, H., Benjamin, J. B., & Yocum, D. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci728 · Cited by 332
Cauwe, B., & Opdenakker, G. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.501783 · Cited by 299
Haematological manifestations of lupus
Fayyaz, A., Igoe, A., Kurien, B. T., Danda, D., James, J. A., Stafford, H. A., & Scofield, R. H. (2015) · Lupus Science & Medicine · doi:10.1136/lupus-2014-000078 · Cited by 294
C1q, Autoimmunity and Apoptosis
BOTTO, M. (2002) · Immunobiology · doi:10.1078/0171-2985-00141 · Cited by 289
Gautschi, O., Bigosch, C., Huegli, B., Jermann, M., Marx, A., Chassé, E., Ratschiller, D., Weder, W., Joerger, M., Betticher, D. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.123 · Cited by 275
T cells as therapeutic targets in SLE
Crispín, J. C., Kyttaris, V. C., Terhorst, C., & Tsokos, G. C. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.60 · Cited by 271
Fernandez, D. R., Telarico, T., Bonilla, E., Li, Q., Banerjee, S., Middleton, F. A., Phillips, P. E., Crow, M. K., Oess, S., Muller-Esterl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803600 · Cited by 257
Rajagopalan, S., Somers, E. C., Brook, R. D., Kehrer, C., Pfenninger, D., Lewis, E., Chakrabarti, A., Richardson, B. C., Shelden, E., McCune, W. J., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3198 · Cited by 255
DNA damage by lipid peroxidation products: Implications in cancer, inflammation and autoimmunity
Gentile, F., Arcaro, A., Pizzimenti, S., Daga, M., Cetrangolo, G. P., Dianzani, C., Lepore, A., Graf, M., Ames, P. R. J., & Barrera, G. (2017) · AIMS Genetics · doi:10.3934/genet.2017.2.103 · Cited by 205
Abnormal T cell signal transduction in systemic lupus erythematosus
Kammer, G. M., Perl, A., Richardson, B. C., & Tsokos, G. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10192 · Cited by 139
Nitric Oxide-Dependent Mitochondrial Biogenesis Generates Ca2+ Signaling Profile of Lupus T Cells
Nagy, G., Barcza, M., Gonchoroff, N., Phillips, P. E., & Perl, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3676 · Cited by 132
Immune cells and cytokines in systemic lupus erythematosus: an update
Kyttaris, V. C., Juang, Y.-T., & Tsokos, G. C. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000170479.01451.ab · Cited by 94
Endogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE
Perl, A., Nagy, G., Koncz, A., Gergely, P., Fernandez, D., Doherty, E., Telarico, T., Bonilla, E., & Phillips, P. E. (2008) · Autoimmunity · doi:10.1080/08916930802024764 · Cited by 58
SLE serum induces classical caspase-dependent apoptosis independent of death receptors
Bengtsson, A. A., Gullstrand, B., Truedsson, L., & Sturfelt, G. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.10.003 · Cited by 29
Metadata
- Authors
- Emlen, W., Niebur, J., & Kadera, R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-04-01
- Volume
- 152
- Issue
- 7
- Pages
- 3685-3692
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1585414631
- Cited by
- 552
- References
- 0
- FWCI
- 25.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.